会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 41. 发明授权
    • System with extended range of molecular sensing through integrated multi-modal data acquisition
    • 通过综合多模态数据采集扩展分子感测范围的系统
    • US07659968B2
    • 2010-02-09
    • US12018108
    • 2008-01-22
    • Xuefeng WangDavid D. NolteManoj VarmaBrian WeichelTimothy NorwoodFouad SayeghMing Zhao
    • Xuefeng WangDavid D. NolteManoj VarmaBrian WeichelTimothy NorwoodFouad SayeghMing Zhao
    • G01N21/00G01N21/64
    • G01N21/6452G01N21/253
    • A multi-modal data acquisition system for detecting target material on a biological reaction surface, the system comprising a radiation source for generating an incoming beam that impinges on the biological reaction surface at an oblique incidence angle and produces a reflected beam, an interferometric detector for detecting an interferometric signal from the illuminated surface, the reflected beam being directed to the interferometric detector, a fluorescence detector for detecting a fluorescence signal from the illuminated surface; the fluorescence detector being positioned to substantially minimize the incidence of the reflected beam; and a processing system for receiving the interferometric and fluorescence signals and determining the presence or absence of target material on the biological reaction surface. A reaction surface conditioned for the simultaneous collection of fluorescence, interferometric and other signals. A multi-modal data acquisition system for collecting and processing additional modes, including multiple interferometric, fluorescence and scattering channels.
    • 一种多模式数据采集系统,用于检测生物反应表面上的目标材料,所述系统包括用于产生入射光束的辐射源,该入射光束以倾斜入射角度撞击在生物反应表面上并产生反射光束,干涉检测器 检测来自所述照射表面的干涉信号,所述反射光束被引导到所述干涉检测器;荧光检测器,用于检测来自被照射表面的荧光信号; 荧光检测器被定位成基本上最小化反射光束的入射; 以及用于接收干涉测量和荧光信号并确定生物反应表面上目标材料的存在或不存在的处理系统。 用于同时收集荧光,干涉仪和其他信号的反应表面。 一种多模式数据采集系统,用于收集和处理其他模式,包括多个干涉仪,荧光和散射通道。
    • 45. 发明申请
    • IN-LINE QUADRATURE AND ANTI-REFLECTION ENHANCED PHASE QUADRATURE INTERFEROMETRIC DETECTION
    • 在线渐近和抗反射增强相位差分干涉检测
    • US20070212257A1
    • 2007-09-13
    • US11675359
    • 2007-02-15
    • David NolteManoj VarmaMing Zhao
    • David NolteManoj VarmaMing Zhao
    • G01N21/00
    • G01N21/45G01N21/253G01N21/47G01N21/75G01N21/77G01N33/54373G01N2021/4707G01N2021/7773G01N2021/7779
    • Method and apparatus for use with a probe beam and detector for detecting the presence of a target analyte in a sample. The apparatus includes a substrate; and a biolayer located on the substrate designed to react to target analyte when the sample is deposited on the biolayer. The substrate can be selected to substantially minimize reflectance by the substrate while substantially maintaining scattering by the target analyte. The substrate can be designed so waves reflected by the substrate are substantially in quadrature with waves scattered by target analyte; or so waves reflected by the substrate and scattered by target analyte interfere in the far field and directly create intensity modulation detectable by the detector. The biolayer can include a plurality of spots, and the spots can be grouped into unit cells having specific antibodies and non-specific antibodies for reacting with target analyte.
    • 用于探测束和检测器的用于检测样品中目标分析物的存在的方法和装置。 该装置包括基板; 以及位于衬底上的生物层,设计成当样品沉积在生物层上时与靶分析物反应。 可以选择衬底以基本上最小化衬底的反射率,同时基本上保持靶分析物的散射。 可以设计衬底,使得由衬底反射的波基本上与被靶分析物散射的波正交; 由基板反射并被目标分析物散射的波浪会在远场干扰,并直接产生由检测器可检测的强度调制。 生物层可以包括多个斑点,并且斑点可以分组成具有特异性抗体的单位细胞和用于与靶分析物反应的非特异性抗体。
    • 47. 发明授权
    • Process for separating aromatics by extractive distillation and a composite solvent used therein
    • 通过萃取蒸馏分离芳烃的方法和其中使用的复合溶剂
    • US07078580B2
    • 2006-07-18
    • US10184751
    • 2002-06-28
    • Longsheng TianWencheng TangMing ZhaoYunming ZhangZhifeng BianHuixia SunShijin Wu
    • Longsheng TianWencheng TangMing ZhaoYunming ZhangZhifeng BianHuixia SunShijin Wu
    • C10C7/10C10C7/17
    • B01D3/40C10G7/08C10G21/27
    • This application relates to a composite solvent for separating aromatics by extractive distillation, comprising a main solvent, a solutizer and a modifier. Said solutizer is selected from any one or mixtures of any two of C8–C11 aromatics having different number of carbon atoms, the content of which is 3–39 wt %, and the number of carbon atoms of the lowest aromatic in the solutizer should be greater than that of the highest aromatic in the aromatics to be separated. When the solutizer is selected from any one of C8–C11 aromatics, the composite solvent contains 0.01–10.0 wt % of the modifier; when the solutizer is selected from mixtures of any two of C8–C11 aromatics having different number of carbon atoms, the composite solvent contains 0–10.0 wt % of the modifier. Said main solvent and modifier are independently selected from sulfolane derivatives, N-formyl morpholine, and N-methyl pyrrolidone, provided that the acidity and basicity of the modifier are opposite to those of the main solvent. When the composite solvent is used to recover aromatics by extractive distillation, it is possible to moderate the operation conditions of solvent recovery, increase the yield of aromatics, and make the separated aromatics to be neutral.
    • 本申请涉及通过萃取蒸馏分离芳族化合物的复合溶剂,其包括主要溶剂,溶剂和改性剂。 所述溶剂选自具有不同碳原子数的C 8 -C 11 -C 11芳族化合物的任何一种或其混合物,其含量为3-39重量% ,并且溶剂中最低芳族化合物的碳原子数应大于待分离芳烃中最高芳族化合物的碳原子数。 当溶剂选自C 8 -C 12芳族化合物中的任何一种时,复合溶剂含有0.01-10.0重量%的改性剂; 当溶剂选自具有不同碳原子数的C 2 -C 11 -C 11芳族化合物的任何两种的混合物时,复合溶剂含有0-10.0重量%的改性剂 。 所述主要溶剂和改性剂独立地选自环丁砜衍生物,N-甲酰基吗啉和N-甲基吡咯烷酮,条件是改性剂的酸度和碱度与主要溶剂的酸度和碱度相反。 当通过萃取蒸馏将复合溶剂用于回收芳族化合物时,可以调节溶剂回收的操作条件,提高芳族化合物的产率,并使分离的芳族化合物成为中性。
    • 50. 发明授权
    • Heavy metal chelating agent for oral administration, its synthesis and its uses in medicine and health protection
    • 一种用于口服给药的新型重金属螯合剂,其合成及其在医药和保健中的应用
    • US06306837B1
    • 2001-10-23
    • US09473737
    • 1999-12-28
    • Shiqi PengChao WangMing ZhaoXingwei LiYancheng WuTaigang Mo
    • Shiqi PengChao WangMing ZhaoXingwei LiYancheng WuTaigang Mo
    • A61K3170
    • C07H15/12Y10S514/836
    • The present invention relates to a new kind of heavy metal chelating agents and a preparation process and uses thereof. The said heavy metal chelating agents are expressed in &agr;-[D(+)glucose-1-yl-amino]-&bgr;3-mercapto-(S)-propanoic acid (abbreviated to NGP,I) and/or N,N′-di[D(+)glucose-1-yl]-L-cystine (abbreviated to NGCD,II). In the process of preparation, glucose and cysteine are reacted with a base, with a reducing agent, and the obtained products are acidified to give NGP,I, which can be used in and/or as drugs, health foods and food additives for accelerating the excretion of heavy metals including Pb, Cd, Hg, Al, Sb, As, etc. The structural feature of the compounds of the present invention is that they contain glucose and cysteirie in their molecules. Compared with the heavy metal-excreting drugs of prior art, the compounds of the present invention have four advantages, namely suitability for oral administration, high ability to accelerate the excretion of heavy metals, high selectivity and less toxicity.
    • 本发明涉及一种新型的重金属螯合剂及其制备方法和用途。 所述重金属螯合剂在α-[D(+)葡萄糖-1-基 - 氨基]-β-巯基 - (S) - 丙酸(缩写为NGP,I)和/或N, 二[D(+)葡萄糖-1-基] -L-胱氨酸(缩写为NGCD,II)。 在制备过程中,葡萄糖和半胱氨酸与碱反应,还原剂,将所得产物酸化,得到NGP,I,可用于和/或作为药物的保健食品和食品添加剂加速 重金属的排泄,包括Pb,Cd,Hg,Al,Sb,As等。本发明化合物的结构特征是它们在其分子中含有葡萄糖和半胱氨酸。 与现有技术的重金属排泄物相比,本发明的化合物具有四个优点,即口服适用性,加速重金属排泄能力高,选择性低,毒性小。